Literature DB >> 7555183

Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.

M N Levine, S Z Goldhaber, J M Gore, J Hirsh, R M Califf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7555183     DOI: 10.1378/chest.108.4_supplement.291s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  Management of hemorrhagic events in patients receiving anticoagulant therapy.

Authors:  D G Love
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Deep Vein Thrombosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-06

3.  Treatment of high-risk venous thrombosis patients using low-dose intraclot injections of recombinant tissue plasminogen activator and regional anticoagulation.

Authors:  Richard Chang; John A Butman; Russell R Lonser; Richard M Sherry; Prakash K Pandalai; McDonald K Horne; Jay N Lozier
Journal:  J Vasc Interv Radiol       Date:  2013-01       Impact factor: 3.464

Review 4.  Emerging concepts in the diagnosis and management of venous thromboembolism during pregnancy.

Authors:  M M Burns
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

5.  Risk factors for major bleeding in the SEATTLE II trial.

Authors:  Immad Sadiq; Samuel Z Goldhaber; Ping-Yu Liu; Gregory Piazza
Journal:  Vasc Med       Date:  2017-01-31       Impact factor: 3.239

Review 6.  Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper.

Authors:  Paul Abraham; Diego A Arroyo; Raphael Giraud; Henri Bounameaux; Karim Bendjelid
Journal:  Open Heart       Date:  2018-02-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.